Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...
July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...
1d
First for Women on MSNSelena Gomez's Lupus Journey: The Signs She Wishes She Hadn't IgnoredSelena Gomez has been in the spotlight thanks to her Golden Globe nomination for Emilia Pérez and her engagement to musician ...
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...
Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.
A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...
Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA Dr J P Lynch III, Department of Internal Medicine, Division of Pulmonary and Critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results